Endoscopic laser treatment for tracheal obstruction

Area of Science:

• Pulmonology
• Oncology
• Gastroenterology

Background:

• Endoluminal tracheal obstruction significantly impacts patient quality of life and respiratory function.
• Malignant and benign tracheal tumors, along with inflammatory conditions, are common causes of severe tracheal stenosis.

Purpose of the Study:

• To evaluate the efficacy of endoscopic laser treatment (ELT) for patients with endoluminal tracheal obstruction.
• To assess clinical, endoscopic, and ventilatory function improvements post-ELT.

Main Methods:

• A neodymium: yttrium aluminium, garnet (Nd:YAG) laser was used on 60 patients with >50% tracheal stenosis.
• Patients were categorized into primary tracheal malignancy (PTM), secondary tracheal malignancy (STM), benign tracheal tumors (BTT), and inflammatory tracheal stenosis (ITS) groups.
• Ventilatory function tests (FVC, PEFR) and clinical/endoscopic assessments were performed pre- and post-treatment.

Main Results:

• Peak expiratory flow rate (PEFR) significantly improved overall and in PTM, STM, and ITS groups.
• No significant improvement in forced vital capacity (FVC) was observed.
• 98% of patients reported subjective improvement; survival varied by group, with long-term survival in some PTM and BTT cases.

Conclusions:

• Endoscopic laser treatment (ELT) is effective for palliating malignant tracheal obstruction, with occasional long-term survival.
• ELT is a valuable treatment for benign tracheal neoplasia and inflammatory stenosis, offering potential for cure.
• The procedure demonstrates a favorable safety profile with no treatment-related mortality.